XBiotech (XBIT) News Today

American Century Companies Inc. purchased a new stake in XBiotech Inc. (NASDAQ:XBIT - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 76,460 shares of the biopharmaceutical company's stock, valued at appro

XBiotech (NASDAQ:XBIT) Stock Passes Above 50 Day Moving Average of $6.22

XBiotech (NASDAQ:XBIT) Share Price Passes Above 50-Day Moving Average of $6.35

XBiotech Inc. (NASDAQ:XBIT - Get Free Report) was the target of a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 946,100 shares, a growth of 68.0% from the June 30th total of 563,100 shares. Approximately 4.8% of the company's stock are short sold. Based on an average daily trading volume, of 131,100 shares, the days-to-cover ratio is presently 7.2 days.

XBiotech Inc. (NASDAQ:XBIT - Get Free Report) was the recipient of a large drop in short interest in June. As of June 30th, there was short interest totalling 563,100 shares, a drop of 14.3% from the June 15th total of 657,300 shares. Approximately 2.9% of the shares of the stock are short sold. Based on an average trading volume of 133,100 shares, the short-interest ratio is presently 4.2 days.

XBiotech Inc. (NASDAQ:XBIT - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 537,500 shares, an increase of 35.4% from the February 14th total of 397,000 shares. Currently, 2.7% of the company's shares are sold short. Based on an average daily trading volume, of 36,700 shares, the short-interest ratio is presently 14.6 days.

XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving Average of $4.56

XBiotech (NASDAQ:XBIT) Shares Cross Above 50 Day Moving Average of $4.37

StockNews.com initiated coverage on XBiotech in a report on Wednesday. They issued a "sell" rating on the stock.

XBiotech Inc. (NASDAQ:XBIT - Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 254,400 shares, an increase of 72.4% from the August 31st total of 147,600 shares. Approximately 1.4% of the shares of the company are sold short. Based on an average daily volume of 21,400 shares, the short-interest ratio is presently 11.9 days.

StockNews.com began coverage on shares of XBiotech in a research report on Friday. They issued a "hold" rating for the company.

StockNews.com started coverage on XBiotech in a research note on Tuesday. They set a "hold" rating for the company.

StockNews.com cut XBiotech from a "hold" rating to a "sell" rating in a report on Tuesday.

XBiotech Inc. (NASDAQ:XBIT - Get Rating) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 96,100 shares, a growth of 42.4% from the October 15th total of 67,500 shares. Based on an average daily volume of 42,800 shares, the short-interest ratio is currently 2.2 days. Approximately 0.6% of the shares of the company are sold short.

StockNews.com lowered shares of XBiotech from a "hold" rating to a "sell" rating in a research report on Tuesday.